BusinessUpdated 1 hr ago
Dr. Reddy’s gets marketing authorisation for generic semaglutide injection in Brazil

Approval expands access for type 2 diabetes treatment; company plans launch with Aché in $244.6 million market
Continue reading on BusinessLine
Read full story Hello Headlines links you to the original publisher for the full story.



